Rakovina Therapeutics

Revolutionizing Drug Discovery with AI

Unlocking New Frontiers in Cancer Treatment to Improve Patient Outcomes

We use cutting edge Deep Docking™ AI to target DNA-damage response (DDR) mechanisms and create innovative precision medicines with the potential to improve patient outcomes across multiple tumor types.

DDR is a collection of processes that identify and correct DNA damage in our cells millions of times every day.

Many cancers harbor a defect in natural DDR mechanisms that allow tumor cells to evade the human immune system and grow unchecked into life-threatening malignancies.